Abstract 5712: Anti-TIGIT antibody tiragolumab leverages myeloid cells and regulatory T cells to improve PD-L1 checkpoint blockade
Patil, Namrata S., Srivats, Shyam, Choi, Yoonha, Guan, Xiangnan, Nabet, Barzin, McGinnis, Lisa, Chiang, Eugene, Dunkle, Alexis, O’Gorman, Bill, Chang, Patrick S., Hu, Ruozhen, Silva, John, Han, Joy, Au-Yeung, Amelia, Takahashi, Chikara, Molden, Nandini, Daggumati, Pallavi, Connolly, Wendy, Johnson, Melissa, Abreu, Delvys Rodriguez, Cho, Byoung Chul, Italiano, Antoine, Gil-Bazo, Ignacio, Felip, Enriqueta, Mellman, Ira, Meng, Raymond, Mariathasan, Sanjeev, Johnston, Robert, Shames, David S.
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article
Abstract 5705: Digital pathology based prognostic & predictive biomarkers in metastatic non-small cell lung cancer
Qamra, Aditi, Srivastava, Minu K., Fuentes, Eloisa, Trotter, Ben, Biju, Raymond, Chhor, Guillaume, Cowan, James, Gendreau, Steven, Lincoln, Webster, McGinnis, Lisa, Molinero, Luciana, Patil, Namrata S., Schedlbauer, Amber, Schulze, Katja, Stanford-Moore, Adam, Chambre, Laura, Wapinski, Ilan, Shames, David S., Koeppen, Hartmut, Hennek, Stephanie, Fridlyand, Jane, Giltnane, Jennifer M., Amitai, Assaf
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article
OA20.01 Tumor Mutation Burden (TMB) is Associated with Improved Efficacy of Atezolizumab in 1L and 2L+ NSCLC Patients
Kowanetz, Marcin, Zou, Wei, Shames, David, Cummings, Craig, Rizvi, Naiyer, Spira, Alexander, Frampton, Garrett, Leveque, Vincent, Flynn, Susan, Mocci, Simonetta, Shankar, Geetha, Funke, Roel, Ballinger, Marcus, Waterkamp, Daniel, Chen, Daniel, Sandler, Alan, Hampton, Garret, Amler, Lukas, Hegde, Priti, Hellmann, Matthew
Published in Journal of thoracic oncology (01.01.2017)
Published in Journal of thoracic oncology (01.01.2017)
Get full text
Journal Article
Characterization of PD-L1 expression in Chinese non-small cell lung cancer patients with PTEN expression as a means for tissue quality screening
Zhang, Xu-chao, Cao, Xu, Sun, Chun, Xie, Zhi, Guo, Jian-jun, Yang, Jin-ji, Yang, Xue-ning, Dai, Hang-jun, Li, Su-chun, Xu, Xin-ran, Zuo, Yun-xia, Chen, Meng, Koeppen, Hartmut, He, Jing, Kiermaier, Astrid, Shames, David, Cheng, Gang, Wu, Yi-long
Published in Cancer Immunology, Immunotherapy (01.03.2018)
Published in Cancer Immunology, Immunotherapy (01.03.2018)
Get full text
Journal Article
A randomized, double-blind, phase II study of first-line FOLFOX plus bevacizumab with onartuzumab versus placebo in patients with metastatic colorectal cancer (mCRC)
Bendell, Johanna C., Hochster, Howard S., Hart, Lowell L., Firdaus, Irfan, Mace, Joseph Ronald, McFarlane, Joshua Jemison, Kozloff, Mark, Catenacci, Daniel Virgil Thomas, Hsu, Jessie J., Hack, Stephen Paul, Shames, David S., Phan, See-Chun, Cohn, Allen Lee
Published in Journal of clinical oncology (20.01.2015)
Published in Journal of clinical oncology (20.01.2015)
Get full text
Journal Article
P2.06-019 A Phase II Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Patients (pts) with Resectable Non-Small Cell Lung Cancer (NSCLC)
Owen, Dwight, Bunn, Paul, Johnson, Bruce, Kwiatkowski, David, Kris, Mark, Wistuba, Ignacio, Gandhi, Mayank, Phan, See, Shames, David, Schulze, Katja, Bernaards, Coen, Aisner, Dara, Chaft, Jamie, Gainor, Justin, Lee, Jay, Minna, John, Mino-Kenudson, Mari, Garcia-Prieto, Celia, Rusch, Valerie, Sabichi, Anita, Villaruz, Liza, Wozniak, Antoinette, Carbone, David
Published in Journal of thoracic oncology (01.01.2017)
Published in Journal of thoracic oncology (01.01.2017)
Get full text
Journal Article
P2.06-019 A Phase II Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Patients (pts) with Resectable Non-Small Cell Lung Cancer (NSCLC): Topic: Phase II + NK
Owen, Dwight, Bunn, Paul, Johnson, Bruce, Kwiatkowski, David, Kris, Mark, Wistuba, Ignacio, Gandhi, Mayank, Phan, See, Shames, David, Schulze, Katja, Bernaards, Coen, Aisner, Dara, Chaft, Jamie, Gainor, Justin, Lee, Jay, Minna, John, Mino-Kenudson, Mari, Garcia-Prieto, Celia, Rusch, Valerie, Sabichi, Anita, Villaruz, Liza, Wozniak, Antoinette, Carbone, David
Published in Journal of thoracic oncology (01.01.2017)
Published in Journal of thoracic oncology (01.01.2017)
Get full text
Journal Article
Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary adenocarcinomas
Brasch, R C, Shames, D M, Cohen, F M, Kuwatsuru, R, Neuder, M, Mann, J S, Vexler, V, Mühler, A, Rosenau, W
Published in Investigative radiology (01.06.1994)
Published in Investigative radiology (01.06.1994)
Get more information
Journal Article
Abstract POSTER-THER-1441: Biomarker evaluation of phase 1 clinical trials of antibody-drug conjugates (ADCs) in platinum resistant ovarian cancer
Wang, Yulei, Firestein, Ron, Ryner, Lisa, Darbonne, Walter, Guan, Yinghui, Lu, Shan, Choi, YJ, Xiao, Yuanyuan, Polakis, Paul, Suttmann, Becky, Desai, Rupal, Fu, Ling, Saad, Ola, Poon, Kirsten Achilles, Denker, Mitch, Leveque, Vincent, Sumiyoshi, Teiko, Lackner, Mark, Shames, David, Humke, Eric, Mayslar, Daniel
Published in Clinical cancer research (15.08.2015)
Published in Clinical cancer research (15.08.2015)
Get full text
Journal Article
Abstract 3500: Analysis of the prevalence and prognostic significance of 92 endpoints using high throughput multiplexed qPCR In archival tissue from multiple NSCLC trials
Do, An D., Sumiyoshi, Teiko, Wang, Yulei, Schleifman, Erica, Xiao, Yuanyuan, Klughammer, Barbara, Wong, Cheryl V., Abbas, Ilma, Fu, Ling, Amler, Lukas C., Raja, Rajiv, Shames, David S.
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Get full text
Journal Article
Molecular, immune and histopathological characterization of NSCLC based on PDL1 expression on tumor and immune cells and association with response to the anti-PDL1 antibody MPDL3280A
Gettinger, Scott N., Kowanetz, Marcin, Koeppen, Hartmut, Wistuba, Ignacio Ivan, Kockx, Mark, Kadel, Edward E., Rizvi, Naiyer A., Spira, Alexander I., Hirsch, Fred R., Boyd, Zachary, Denker, Mitchell, Minn, Alexandra, Shames, David S., Sandler, Alan, Chen, Daniel S., Hegde, Priti S., Spigel, David R.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Biomarker Analyses from a Placebo-Controlled Phase II Study Evaluating Erlotinib plus or minus Onartuzumab in Advanced Non-Small Cell Lung Cancer: MET Expression Levels Are Predictive of Patient Benefit
Koeppen, Hartmut, Yu, Wei, Zha, Jiping, Pandita, Ajay, Penuel, Elicia, Rangell, Linda, Raja, Rajiv, Mohan, Sankar, Patel, Rajesh, Desai, Rupal, Fu, Ling, Do, An, Parab, Vaishali, Xia, Xiaoling, Januario, Tom, Louie, Sharianne G, Filvaroff, Ellen, Shames, David S, Wistuba, Ignacio, Lipkind, Marina, Huang, Jenny, Lazarov, Mirella, Ramakrishnan, Vanitha, Amler, Lukas, Phan, See-Chun, Patel, Premal, Peterson, Amy, Yauch, Robert L
Published in Clinical cancer research (01.09.2014)
Published in Clinical cancer research (01.09.2014)
Get full text
Journal Article
Identification of head and neck cancers (SCCHN) that may respond to dual inhibition of EGFR and HER3 signaling
Shames, David S., Stern, Howard, Walter, Kim, Jiang, Brittany, Fu, Ling, Do, An, Raja, Rajiv, Wilson, Tim, Settleman, Jeff, Sliwkowski, Mark X., Pirzkall, Andrea, Amler, Lukas C.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Multimodality determination of HPV status in head and neck cancers (HNC) and development of an HPV signature
Zuo, Zhixiang, Keck, Michaela K., Khattri, Arun, Patel, Rajesh D., Walter, Kim, Lingen, Mark W., White, Kevin P., Hammerman, Peter S., Cohen, Ezra E.W., Stenson, Kerstin, Blair, Elizabeth A., Shames, David S., Vokes, Everett E., Seiwert, Tanguy Y.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
A phase I study of the safety and pharmacokinetics of DNIB0600A, an anti-NaPi2b antibody-drug-conjugate (ADC), in patients (pts) with non− small cell lung cancer (NSCLC) and platinum-resistant ovarian cancer (OC)
Gordon, Michael S., Gerber, David E., Infante, Jeffrey R., Xu, Jian, Shames, David S., Choi, Younjeong, Kahn, Robert S., Lin, Kedan, Wood, Katie, Maslyar, Daniel J., Burris, Howard A.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Abstract 1732: DNA methylation profiling defines clinically relevant biological subsets of non-small cell lung cancer
Walter, Kim, Holcomb, Thomas, Januario, Tom, Du, Pan, Hampton, Garret M., Amler, Lukas C., Yauch, Robert L., Bourgon, Richard, Shames, David S.
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Get full text
Journal Article
Abstract 1147: Molecular characterization of PI3K pathway alterations in non-small cell lung carcinoma
Huw, Ling-Yuh, Spoerke, Jill, O'Brien, Carol, Koeppen, Hartmut, Fridlyand, Jane, Amler, Lukas, Hampton, Garret, Shames, David, Lackner, Mark, Pandita, Ajay
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Get full text
Journal Article